1887

n CME : Your SA Journal of CPD - Protos : the first dual action bone agent for osteoporosis : health awareness

USD

 

Abstract

Extracted from text ... health awareness June 2006 Vol.24 No.6 CMe 341 health awareness servier laboratories has announced the launch of its new osteoporosis drug Protos (strontium ranelate) in south africa. Indicated for the treatment of postmenopausal osteoporosis to reduce the risk of both vertebral and non-vertebral fractures, including the hip, Protos is a new first-line option in the treatment of postmenopausal osteoporosis. the first in a new therapeutic class, Protos is categorised as a 'dual action bone agent' as it has a particular profile which is characterised by a simultaneous inhibition of bone resorption and a stimulation of bone formation. now, for ..

Loading

Article metrics loading...

/content/m_cme/24/6/EJC63143
2006-06-01
2016-12-06
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error